MBF Therapeutics

Overview
Animal Therapeutics?
Product stageSegments
Pre-Seed
?
Oncology therapeutics, Next-generation vaccines and drugs
?

MBF Therapeutics is a veterinary oncology company dedicated to developing innovative immunotherapies for treating cancer and infectious diseases in companion animals and livestock. The company's proprietary checkpoint inhibitor technology, based on the Wistar Institute's intellectual property, serves as a platform for creating multiple prophylactic and therapeutic products for animal health markets worth over USD 5 billion.

MBF Therapeutics focuses on utilizing its innovative T-Max DNA vaccine platform to address serious problems in animal health. This approach aims to establish proof-of-concept clinical data, paving the way for exploring specific opportunities in human health through separately funded subsidiaries and partnerships with major vaccine companies.

The company is actively working with Dr. Hildegund Ertl at the Wistar Institute and veterinary oncologists to develop a cancer vaccine for treating dogs with melanoma. MBF Therapeutics embraces the concept of "One World, One Health," recognizing the interrelationships between diseases in animals and humans. By addressing these threats, the company seeks to create safe and innovative approaches to protect both animals and humans.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
640 Woodbrook Drive Ambler PA USA
Founded year:
2008
Employees:
1-10
IPO status:
Private
Total funding:
USD 851.0 k
Last Funding:
USD 256.0 k (Grant; Dec 2021)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.